Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood

Journal of Psychopharmacology

Volumn 16, Issue 4, 2002, Pages 321-331

  Wilson, S J ^a   Bailey, J E ^c   Alford, C ^c   Weinstein, A ^c   Nutt, D J ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^c NONE

Author keywords

Driving; MSLT; Psychomotor performance; Sleep; SSRIs; TCAs

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; DOSULEPIN; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT; LACTOSE; PLACEBO;

ADULT; AFFECT; ARTICLE; ATTENTION; BLOOD; CAR DRIVING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; HUMAN; MALE; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SACCADIC EYE MOVEMENT; SLEEP; SLEEP STAGE; ALERTNESS; CLINICAL ARTICLE; DEPRESSION; DRIVING ABILITY; ELECTROENCEPHALOGRAM; LATENT PERIOD; MENTAL DISEASE; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RATING SCALE; REACTION TIME; SEDATION; SIDE EFFECT;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AFFECT; ATTENTION; AUTOMOBILE DRIVING; CROSS-OVER STUDIES; DOTHIEPIN; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FLUOXETINE; HUMANS; MALE; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; SACCADES; SEROTONIN UPTAKE INHIBITORS; SLEEP; SLEEP STAGES; SLEEP, REM;

EID: 0036904146     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600406     Document Type: Article

References (52)

1. Alford C, Bhatti J Z, Curran S, McKay G, Hindmarch I (1991) Pharmacodynamic effects of buspirone and clobazam in normal subjects. Br J Clin Pharmacol 32: 91-97
2. Alford C, Rombaut N, Jones J, Foley S, Idzikowski C, Hindmarch I (1992) Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: A C-EEG study. Hum Psychopharmacol 7: 25-37
3. Allen D A, Lader M, Curran H V (1988) A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in healthy subjects. Prog NeuroPsychopharmacol Biol Psychiatry 12: 63-80
4. Armitage R, Yonkers K, Cole D, Rush A J (1997) A multicentre, double blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 17: 161-168
5. Belenky G, Williams J D, Redmond D P, Reichardt R M, Russo M B, Sing H C, Thomas M L, Wesensten N J, Balkin T J (2001) Individual differences in performance degradation and subsequent recovery in volunteers allowed 3 h sleep time in 7 days. Sleep 24 (Suppl.): A29
6. Bishop C, Rosenthal L, Helmus T, Roehrs T, Roth T (1996) The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness. Sleep 191: 727-730
7. Blacker R, Shanks N J, Chapman N, Davey A (1988) The drug treatment of depression in general practice: A comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptryline. Psychopharmacology 95: S18-S24
8. Blom M W, Bartel P R, de Sommers K, van der Meyden C H, Becker P J (1990) The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor performance and the EEG. Fundam Clin Pharmacol 4: 653-661
9. Brice C, Smith A. (2001) The effects of caffeine on simulated driving, subjective alertness and sustained attention. Hum Psychopharmacol Clin Exp 16:523-531
10. Carskadon M A, Dement WC (1982) The multiple sleep latency test: What does it measure? Sleep 5: S67-S72
11. Curran H V, Shine P, Lader M (1986) Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation. Psychopharmacology 89: 360-363
12. Currie D, Hashemi K, Fothergill J, Findlay A, Harris A, Hindmarch, I. (1995) The use of anti-depressants and benzodiazepines in the perpetrators and victims of accidents. Occupat Med (Oxford). 45: 323-325
13. Cusack B, Nelson A, Richelson E (1994) Binding of antidepressants to human brain receptors: Focus on newer generation compounds. Psychopharmacology 114: 559-565
14. Department of Health (1992) The Health of the Nation: A Strategy for Health in England. HMSO, London
15. Dunn R L, Donoghue J M, Ozminkowski R J, Stephenson D, Hylan T R. (1999) Longitudinal patterns of antidepressant prescribing in primary care in the UK: Comparison with treatment guidelines. J Psychopharmacol 13:136-143
16. Edwards G (1995) Depression, antidepressants and accidents. BMJ 311: 887-888
17. Friedman L, Jesberger J A, Meltzer H Y (1994) The effect of apomorphine, MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine) and placebo on smooth pursuit gain and corrective saccades in normal subjects. Neuropsychopharmacology 11: 49-62
18. Gillin J C, Rapaport M. Erman M K, Winokur A, Albala B J (1997) A comparison of nefazodone and fluoxetine on objective, subjective and clinician-rated measures of sleep in depressed patients: A double-blind 8 week clinical trial. J Clin Psychiatry 58: 222
19. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C (1996) A randomized double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheumatol 39: 1852-1859
20. Griffiths A N, Jones D, Mercer A, Wroe S, Richens A (1986) The effect of nefopam alone and in combination with ethanol on human psychomotor performance, ventilatory response to hypercapnia and mood. Br J Pharmacol 89 (Suppl.): 707
21. Hendrickse W A, Roffwarg H P, Granneman B D, Orsulak P J, Armitage R, Cain J W, Battaglia J, Debus J R, Rush A J (1994) The effects of fluoxetine on the polysomnogram of depressed outpatients: A pilot study. Neuropsychopharmacology 10: 85-91
22. Hindmarch I, Alford C, Barwell F, Kerr J S (1992) Measuring the side effects of psychotropics: The behavioural toxicity of antidepressants. J Psychopharmacol 6: 198-203
23. Kerkhofs M, Rielaert C, de Maertelaer V, Linkowski P, Zarka M, Mendlewicz J (1990) Fluoxetine in major depression: Efficacy, safety and effects on sleep polygraphic variables. Int Clin Psychopharmacol 5: 253-260
24. Kerr J S, Fairweather D B, Hindmarch I (1997) The effect of paroxetine and dothiepin on subjective sleep in depressed patients. Hum Psychopharmacol 12: 71-73
25. Lancaster S G, Gonzalez J P (1989) Dothiepin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 38: 124-147
26. Matthews G, Dorn I, Hoyes W, Dacies R, Glendon I, Taylor R G (1998) Driver stress and performance on a driving simulator. Hum Factors 40: 136-149
27. Mercer A, Allen E A, Jones D, Marshall R W, Wroe S, Richens A (1988) The effects of minaprine and chlorpromazine alone and in combination on human psychomotor performance and mood. Br J Clin Pharmacol 25: 680-681
28. Moore P, Gillin J C, Bhatti T, Demodena A, Seifritz E, Clark C, Stahl S, Rapaport M, Kelsoe J (1998) Rapid tryptophan depletion, sleep EEG and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 55: 534-538
29. Moskowitz H, Burns M (1988) The effects on performance of two antidepressants alone and in combination with diazepam. Prog NeuroPsychopharmacol Biol Psychiatry 12: 783-792
30. Nicholson A N, Pascoe P A (1988) Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5HT uptake inhibitor. Neuropharmacology 27: 597-602
31. O'Boyle D J, Van F, Hume K I (1995) Effects of alcohol at two times of day, on EEG-derived indices of physiological arousal. Electroencephalogr Clin Neurophysiol 95: 97-107
32. Parrot A C, Hindmarch I (1978) A factor analysis of a sleep evaluation questionnaire. Psychol Med 8: 325-329
33. Ramaekers J G, Muntjewerff N D, O'Hanlon J F (1995) A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 39: 397-404
34. Ray W A, Fought R L, Decker M D (1992) Psychoactive drugs and the risks of injurious motor vehicle crashes in elderly drivers. Am J Epidemiology 136: 873-883
35. Rechtschaffen A, Kales A (1968) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. US Department of HEW, Washington
36. Roehrs T, Zwyghuizen-Doorenbos A, Roth T (1993) Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo. Sleep 16(4): 301-305
37. Roy-Byrne P P, Cowley D S, Radant A, Hommer D, Greenblatt D J (1993) Benzodiazepine pharmacodynamics: Utility of eye movement measures. Psychopharmacology 110: 85-91
38. Rush A J, Armitage R, Gillin J C, Yonkers K A, Winokur A, Moldofsky H, Vogel G W, Kaplita S, Fleming J B, Montplaisir J, Erman M K, Albala B, McQuade R D (1998) Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 44: 3-14
39. Sakulsripong M, Curran H V, Lader M (1991) Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo Eur J Clin Pharmacol 40: 43-48
40. Satterlee W G, Faries D E (1995) The effects of fluoxetine on symptoms of insomnia in depressed patients. Psychopharmacol Bull 31: 227-237
41. Sharpley A (1996) Impact of daytime sleepiness underrated. Lancet 348: 71
42. Smith A, Rich N (1998) Effects of consumption of snacks on simulated driving. Percept Motor Skills 87: 817-818
43. Tedeschi G, Smith A T, Richens A (1984) Effect of meptazenol and ethanol on human psychomotor performance and mood rating. Human Toxicol 3: 33-34
44. Torsvall L, Akerstedt T (1987) Sleepiness on the job: Continuously measured EEG changes in train drivers. Electroencephalogr Clin Neurophysiol 66: 502-511
45. van Steveninck A L, Schoemaker H C, Pieters M S, Kroon R, Breimer D D, Cohen A F (1991) A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analogue lines to the effects of incremental doses of temazepam in healthy volunteers. Clin Pharmacol Ther 50: 172-180
46. Vasar V, Appelberg B, Rimon R, Selvaratnam J (1994) The effect of fluoxetine on sleep: A longitudinal double blind polysomnographic study of healthy volunteers. Int Clin Psychopharmacol 9: 203-206
47. Vercoulen J H, Swanink C M, Zitman F G, Vreden S G, Hoofs M P, Fennis J F, Galama J M, Van Der Meer J W M, Bleijenberg G (1996) Randomised double blind placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347: 858-861
48. Volz H-P, Sturm Y (1995) Antidepressant drugs and psychomotor performance. Neuropsychobiology 31: 146-155
49. Weinstein A, Wilson S, Bailey J, Nutt D J (1996) Sedative antidepressants impair visual detection mechanisms in humans. J Psychopharmacol 10: 141-145
50. Wilson S J, Glue P, Ball D, Nutt D J (1993) Saccadic eye movements in normal subjects. Electroencephalogr Clin Neurophysiol 86: 69-74
51. Wilson S J, Bailey J E, Alford C. Nutt D J (2000a) Sleep and daytime sleepiness the next day following single nighttime dose of fluvoxamine, dothiepin and placebo in normal volunteers. J Psychopharmacol 14: 378-386
52. Wilson S J, Bell C, Coupland NJ, Nutt D J (2000b) Sleep changes during long-term treatment of depression with fluvoxamine - A home based study. Psychopharmacology 149: 360-365